Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

StemCells Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

31 Jul 2015 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for STEM

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

03 Aug 2015 ValuEngine, Inc. 10 $25.00

Thomson Reuters Stock Report - StemCells Inc (STEM-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

03 Aug 2015 Thomson Reuters Stock Report 11 $25.00

STEM: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

03 Aug 2015 New Constructs, LLC 10 $25.00

STEMCELLS INC (STEM) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

01 Aug 2015 Pechala's Reports 1 $15.00

STEMCELLS INC (STEM) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

01 Aug 2015 Pechala's Reports 1 $25.00

ValuEngine Industry Report for Medical-Biomed/Genetics(STEM)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

31 Jul 2015 ValuEngine, Inc. 10 $49.00

Value Graph: STEMCELLS -- STEM

31 Jul 2015 Ford Investor Services, Inc. 1 $12.00

StemCells Inc.: Undervalued Based on Early Data in Spine

The following is an excerpt from the Streetwise Reports interview with Caroline Corner, managing director and senior analyst ...

29 Jul 2015 Streetwise Reports 2 $12.00

Cutting-Edge Devices and Diagnostics Deliver Drugs and Profits: Cantor Fitzgerald's Caroline Corner

Medical technology is not considered a huge-margin investment in the way that the biotech and drug industries are. However, ...

29 Jul 2015 Streetwise Reports 9 $92.00